Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Pneumonia Vaccine Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Pneumonia Vaccine Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

Pneumonia vaccines are vaccines against Streptococcus pneumococcus. Their use can help in preventing some cases of pneumonia as well as meningitis and sepsis. There are two types of pneumonia vaccines: polysaccharide vaccines and monovalent vaccines. The pneumococcal pneumonia vaccines include all the vaccines in the following groups: group A Streptococcus pneumococcus, group B Streptococcus pneumococcus, and c-strains of Streptococcus bacterium. Group A and group B vaccines are given to individuals and children at birth. The c-strains include S pneumonia and N pneumonia. As these are the main causes of this illness, these vaccines are given early. The other types include group C, group D, and group E pneumococcus. All these are classified as pneumococcal conjugates, monovalent, or polysaccharides.

The growing prevalence of pneumonia is driving the market growth of the pneumonia vaccine. According to the World Health Organization, Pneumonia accounts for 15% of all deaths of children under 5 years old, killing 808 694 children in 2017. Accounting for 15% of all deaths of children under five years old. Pneumonia affects children and families everywhere but is most prevalent in South Asia and sub-Saharan Africa. Moreover, increasing initiatives by the government to create awareness regarding pneumonia immunization is again fueling the market growth of the pneumonia vaccine. On the other hand, higher costs associated with the production of the vaccines are projected to hinder the market growth over the forecast period.

North America is expected to gain significant growth over the forecast period and this is attributed to growing research & development on pneumonia vaccine due to the increasing disease burden in the region. For instance, in March 2020, Pfizer Inc. announced top-line results from one of its Phase 3 studies (NCT03760146), which evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate in adults 18 years of age or older not previously vaccinated against pneumococcal disease.

Key Developments:

  • In June 2020, Merck announced results of two initial Phase 3 studies evaluating the safety, tolerability, and immunogenicity of V114, the company’s investigational 15-valent pneumococcal conjugate vaccine.
  • In January 2020, the pneumococcal vaccine developed by the Pune-based Serum Institute of India is expected to become available in the private market in June this year.
  • In June 2020, The Serum Institute of India announced that it will provide ten million doses of the pneumococcal conjugate vaccine, which helps to prevent severe pneumonia, every year to lower-income countries for the next decade under a new supply agreement with the UNICEF that helped dramatically decreased the price of pneumonia vaccine for those nations.

The Pneumonia Vaccine Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Pneumonia Vaccine Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Pfizer Inc.
  • Glaxosmithkline Plc.
  • Merck & Co., Inc.
  • Sanofi Pasteur
  • Serum Institute of India Pvt. Ltd.
  • Johnson & Johnson
  • Astellas Pharma Inc.
  • Astrazeneca Plc.
  • CSL Limited
  • Emergent Biosolutions

By the Product Type, the market is primarily segmented into:

  • Pneumococcal Conjugate Vaccine (PCV13)
  • Pneumococcal Polysaccharide Vaccine (PPSV23)

By Applications, the market is segmented into:

  • Pneumonia
  • Meningitis
  • Sepsis

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Pneumonia Vaccine Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Pneumonia Vaccine Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Pneumonia Vaccine Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Pneumonia Vaccine Market

The Pneumonia Vaccine Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Pneumonia Vaccine Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Pneumonia Vaccine Market Overview
1.1 Product Overview and Scope of Pneumonia Vaccine
1.2 Pneumonia Vaccine Segment by Type
1.2.1 Global Pneumonia Vaccine Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.3 Pneumonia Vaccine Segment by Application
1.3.1 Pneumonia Vaccine Consumption Comparison by Application (2014-2025)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Global Pneumonia Vaccine Market by Region
1.4.1 Global Pneumonia Vaccine Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Pneumonia Vaccine Market Size
1.5.1 Global Pneumonia Vaccine Revenue (2014-2025)
1.5.2 Global Pneumonia Vaccine Production (2014-2025)

2 Global Pneumonia Vaccine Market Competition by Manufacturers
2.1 Global Pneumonia Vaccine Production Market Share by Manufacturers (2014-2019)
2.2 Global Pneumonia Vaccine Revenue Share by Manufacturers (2014-2019)
2.3 Global Pneumonia Vaccine Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Pneumonia Vaccine Production Sites, Area Served, Product Types
2.5 Pneumonia Vaccine Market Competitive Situation and Trends
2.5.1 Pneumonia Vaccine Market Concentration Rate
2.5.2 Pneumonia Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Pneumonia Vaccine Production Market Share by Regions
3.1 Global Pneumonia Vaccine Production Market Share by Regions
3.2 Global Pneumonia Vaccine Revenue Market Share by Regions (2014-2019)
3.3 Global Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Pneumonia Vaccine Production
3.4.1 North America Pneumonia Vaccine Production Growth Rate (2014-2019)
3.4.2 North America Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Pneumonia Vaccine Production
3.5.1 Europe Pneumonia Vaccine Production Growth Rate (2014-2019)
3.5.2 Europe Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Pneumonia Vaccine Production
3.6.1 China Pneumonia Vaccine Production Growth Rate (2014-2019)
3.6.2 China Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Pneumonia Vaccine Production
3.7.1 Japan Pneumonia Vaccine Production Growth Rate (2014-2019)
3.7.2 Japan Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Pneumonia Vaccine Consumption by Regions
4.1 Global Pneumonia Vaccine Consumption by Regions
4.2 North America Pneumonia Vaccine Consumption (2014-2019)
4.3 Europe Pneumonia Vaccine Consumption (2014-2019)
4.4 China Pneumonia Vaccine Consumption (2014-2019)
4.5 Japan Pneumonia Vaccine Consumption (2014-2019)

5 Global Pneumonia Vaccine Production, Revenue, Price Trend by Type
5.1 Global Pneumonia Vaccine Production Market Share by Type (2014-2019)
5.2 Global Pneumonia Vaccine Revenue Market Share by Type (2014-2019)
5.3 Global Pneumonia Vaccine Price by Type (2014-2019)
5.4 Global Pneumonia Vaccine Production Growth by Type (2014-2019)

6 Global Pneumonia Vaccine Market Analysis by Applications
6.1 Global Pneumonia Vaccine Consumption Market Share by Application (2014-2019)
6.2 Global Pneumonia Vaccine Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Pneumonia Vaccine Business
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Pneumonia Vaccine Production Sites and Area Served
7.1.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.1.3 Pfizer Inc. Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Glaxosmithkline Plc.
7.2.1 Glaxosmithkline Plc. Pneumonia Vaccine Production Sites and Area Served
7.2.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Pneumonia Vaccine Production Sites and Area Served
7.3.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.3.3 Merck & Co., Inc. Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Pneumonia Vaccine Production Sites and Area Served
7.4.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.4.3 Sanofi Pasteur Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Serum Institute of India Pvt. Ltd.
7.5.1 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Production Sites and Area Served
7.5.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Pneumonia Vaccine Production Sites and Area Served
7.6.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.6.3 Johnson & Johnson Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Astellas Pharma Inc.
7.7.1 Astellas Pharma Inc. Pneumonia Vaccine Production Sites and Area Served
7.7.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.7.3 Astellas Pharma Inc. Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.8 Astrazeneca Plc.
7.8.1 Astrazeneca Plc. Pneumonia Vaccine Production Sites and Area Served
7.8.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.8.3 Astrazeneca Plc. Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 CSL Limited
7.9.1 CSL Limited Pneumonia Vaccine Production Sites and Area Served
7.9.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.9.3 CSL Limited Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Emergent Biosolutions
7.10.1 Emergent Biosolutions Pneumonia Vaccine Production Sites and Area Served
7.10.2 Pneumonia Vaccine Product Introduction, Application and Specification
7.10.3 Emergent Biosolutions Pneumonia Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 Pneumonia Vaccine Manufacturing Cost Analysis
8.1 Pneumonia Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pneumonia Vaccine
8.4 Pneumonia Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Pneumonia Vaccine Distributors List
9.3 Pneumonia Vaccine Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Pneumonia Vaccine Market Forecast
11.1 Global Pneumonia Vaccine Production, Revenue Forecast
11.1.1 Global Pneumonia Vaccine Production Growth Rate Forecast (2019-2025)
11.1.2 Global Pneumonia Vaccine Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Pneumonia Vaccine Price and Trend Forecast (2019-2025)
11.2 Global Pneumonia Vaccine Production Forecast by Regions (2019-2025)
11.2.1 North America Pneumonia Vaccine Production, Revenue Forecast (2019-2025)
11.2.2 Europe Pneumonia Vaccine Production, Revenue Forecast (2019-2025)
11.2.3 China Pneumonia Vaccine Production, Revenue Forecast (2019-2025)
11.2.4 Japan Pneumonia Vaccine Production, Revenue Forecast (2019-2025)
11.3 Global Pneumonia Vaccine Consumption Forecast by Regions (2019-2025)
11.3.1 North America Pneumonia Vaccine Consumption Forecast (2019-2025)
11.3.2 Europe Pneumonia Vaccine Consumption Forecast (2019-2025)
11.3.3 China Pneumonia Vaccine Consumption Forecast (2019-2025)
11.3.4 Japan Pneumonia Vaccine Consumption Forecast (2019-2025)
11.4 Global Pneumonia Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Pneumonia Vaccine Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures

Figure Picture of Pneumonia Vaccine
Table Global Pneumonia Vaccine Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Pneumonia Vaccine Production Market Share by Types in 2018
Figure Pneumococcal Conjugate Vaccine (PCV13) Product Picture
Table Pneumococcal Conjugate Vaccine (PCV13) Major Manufacturers
Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Product Picture
Table Pneumococcal Polysaccharide Vaccine (PPSV23) Major Manufacturers
Table Global Pneumonia Vaccine Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Pneumonia Vaccine Consumption Market Share by Applications in 2018
Figure Pneumonia
Figure Meningitis
Figure Sepsis
Table Pneumonia Vaccine Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Pneumonia Vaccine Revenue (Million USD) (2014-2025)
Figure Global Pneumonia Vaccine Production (K Doses) (2014-2025)
Table Global Pneumonia Vaccine Production (K Doses) of Key Manufacturers (2014-2019)
Table Global Pneumonia Vaccine Production Share by Manufacturers (2014-2019)
Figure Pneumonia Vaccine Production Share by Manufacturers in 2018
Table Global Pneumonia Vaccine Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Pneumonia Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Global Pneumonia Vaccine Revenue Share by Manufacturers in 2018
Table Global Market Pneumonia Vaccine Average Price (USD/Dose) of Key Manufacturers (2014-2019)
Figure Global Market Pneumonia Vaccine Average Price (USD/Dose) of Key Manufacturers in 2018
Table Manufacturers Pneumonia Vaccine Production Sites and Area Served
Table Manufacturers Pneumonia Vaccine Product Types
Figure Pneumonia Vaccine Market Share of Top 5 Manufacturers
Figure Pneumonia Vaccine Market Share of Top 10 Manufacturers
Table Global Pneumonia Vaccine Production (K Doses) by Region (2014-2019)
Table Global Pneumonia Vaccine Production Market Share by Region (2014-2019)
Figure Global Pneumonia Vaccine Production Market Share by Region (2014-2019)
Figure Global Pneumonia Vaccine Production Market Share by Region in 2018
Table Global Pneumonia Vaccine Revenue (Million USD) by Region (2014-2019)
Table Global Pneumonia Vaccine Revenue Market Share by Region (2014-2019)
Figure Global Pneumonia Vaccine Revenue Market Share by Region (2014-2019)
Figure Global Pneumonia Vaccine Revenue Market Share by Region in 2018
Figure Global Pneumonia Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Global Pneumonia Vaccine Production (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Figure North America Pneumonia Vaccine Production (K Doses) Growth Rate (2014-2019)
Table North America Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Europe Pneumonia Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Europe Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure China Pneumonia Vaccine Production (K Doses) Growth Rate (2014-2019)
Table China Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Japan Pneumonia Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Japan Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Global Pneumonia Vaccine Consumption (K Doses) Market by Region (2014-2019)
Table Global Pneumonia Vaccine Consumption Market Share by Region (2014-2019)
Figure Global Pneumonia Vaccine Consumption Market Share by Region (2014-2019)
Figure Global Pneumonia Vaccine Consumption Market Share by Region in 2018
Figure North America Pneumonia Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure Europe Pneumonia Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure China Pneumonia Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure Japan Pneumonia Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Table Global Pneumonia Vaccine Production (K Doses) by Type (2014-2019)
Table Global Pneumonia Vaccine Production Share by Type (2014-2019)
Figure Production Market Share of Pneumonia Vaccine by Type (2014-2019)
Figure Production Market Share of Pneumonia Vaccine by Type in 2018
Table Global Pneumonia Vaccine Revenue (Million USD) by Type (2014-2019)
Table Global Pneumonia Vaccine Revenue Share by Type (2014-2019)
Figure Revenue Share of Pneumonia Vaccine by Type (2014-2019)
Figure Revenue Market Share of Pneumonia Vaccine by Type in 2018
Table Global Pneumonia Vaccine Price (USD/Dose) by Type (2014-2019)
Figure Global Pneumonia Vaccine Production Growth by Type (2014-2019) (K Doses)
Table Global Pneumonia Vaccine Consumption (K Doses) by Application (2014-2019)
Table Global Pneumonia Vaccine Consumption Market Share by Application (2014-2019)
Figure Global Pneumonia Vaccine Consumption Market Share by Applications (2014-2019)
Figure Global Pneumonia Vaccine Consumption Market Share by Application in 2018
Table Global Pneumonia Vaccine Consumption Growth Rate by Application (2014-2019)
Figure Global Pneumonia Vaccine Consumption Growth Rate by Application (2014-2019)
Table Pfizer Inc. Pneumonia Vaccine Production Sites and Area Served
Table Pfizer Inc. Product Introduction, Application and Specification
Table Pfizer Inc. Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Pfizer Inc. Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Pfizer Inc. Pneumonia Vaccine Production Market Share (2014-2019)
Figure Pfizer Inc. Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Pfizer Inc. Main Business and Markets Served
Table Glaxosmithkline Plc. Pneumonia Vaccine Production Sites and Area Served
Table Glaxosmithkline Plc. Product Introduction, Application and Specification
Table Glaxosmithkline Plc. Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Glaxosmithkline Plc. Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Glaxosmithkline Plc. Pneumonia Vaccine Production Market Share (2014-2019)
Figure Glaxosmithkline Plc. Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Glaxosmithkline Plc. Main Business and Markets Served
Table Merck & Co., Inc. Pneumonia Vaccine Production Sites and Area Served
Table Merck & Co., Inc. Product Introduction, Application and Specification
Table Merck & Co., Inc. Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Merck & Co., Inc. Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Merck & Co., Inc. Pneumonia Vaccine Production Market Share (2014-2019)
Figure Merck & Co., Inc. Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Main Business and Markets Served
Table Sanofi Pasteur Pneumonia Vaccine Production Sites and Area Served
Table Sanofi Pasteur Product Introduction, Application and Specification
Table Sanofi Pasteur Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Sanofi Pasteur Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Sanofi Pasteur Pneumonia Vaccine Production Market Share (2014-2019)
Figure Sanofi Pasteur Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Sanofi Pasteur Main Business and Markets Served
Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Production Sites and Area Served
Table Serum Institute of India Pvt. Ltd. Product Introduction, Application and Specification
Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Production Market Share (2014-2019)
Figure Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Serum Institute of India Pvt. Ltd. Main Business and Markets Served
Table Johnson & Johnson Pneumonia Vaccine Production Sites and Area Served
Table Johnson & Johnson Product Introduction, Application and Specification
Table Johnson & Johnson Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Johnson & Johnson Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Johnson & Johnson Pneumonia Vaccine Production Market Share (2014-2019)
Figure Johnson & Johnson Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Johnson & Johnson Main Business and Markets Served
Table Astellas Pharma Inc. Pneumonia Vaccine Production Sites and Area Served
Table Astellas Pharma Inc. Product Introduction, Application and Specification
Table Astellas Pharma Inc. Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Astellas Pharma Inc. Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Astellas Pharma Inc. Pneumonia Vaccine Production Market Share (2014-2019)
Figure Astellas Pharma Inc. Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Astellas Pharma Inc. Main Business and Markets Served
Table Astrazeneca Plc. Pneumonia Vaccine Production Sites and Area Served
Table Astrazeneca Plc. Product Introduction, Application and Specification
Table Astrazeneca Plc. Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Astrazeneca Plc. Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Astrazeneca Plc. Pneumonia Vaccine Production Market Share (2014-2019)
Figure Astrazeneca Plc. Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Astrazeneca Plc. Main Business and Markets Served
Table CSL Limited Pneumonia Vaccine Production Sites and Area Served
Table CSL Limited Product Introduction, Application and Specification
Table CSL Limited Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure CSL Limited Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure CSL Limited Pneumonia Vaccine Production Market Share (2014-2019)
Figure CSL Limited Pneumonia Vaccine Revenue Market Share (2014-2019)
Table CSL Limited Main Business and Markets Served
Table Emergent Biosolutions Pneumonia Vaccine Production Sites and Area Served
Table Emergent Biosolutions Product Introduction, Application and Specification
Table Emergent Biosolutions Pneumonia Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Emergent Biosolutions Pneumonia Vaccine Production Growth Rate (2014-2019)
Figure Emergent Biosolutions Pneumonia Vaccine Production Market Share (2014-2019)
Figure Emergent Biosolutions Pneumonia Vaccine Revenue Market Share (2014-2019)
Table Emergent Biosolutions Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumonia Vaccine
Figure Manufacturing Process Analysis of Pneumonia Vaccine
Figure Pneumonia Vaccine Industrial Chain Analysis
Table Pneumonia Vaccine Distributors List
Table Pneumonia Vaccine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Pneumonia Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Global Pneumonia Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Pneumonia Vaccine Price and Trend Forecast (2019-2025)
Table Global Pneumonia Vaccine Production (K Doses) Forecast by Region (2019-2025)
Figure Global Pneumonia Vaccine Production Market Share Forecast by Region (2019-2025)
Figure North America Pneumonia Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure North America Pneumonia Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Pneumonia Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Europe Pneumonia Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Pneumonia Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure China Pneumonia Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Pneumonia Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Japan Pneumonia Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Pneumonia Vaccine Consumption (K Doses) Forecast by Regions (2019-2025)
Figure Global Pneumonia Vaccine Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Pneumonia Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Europe Pneumonia Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure China Pneumonia Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Japan Pneumonia Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Table Global Pneumonia Vaccine Production (K Doses) Forecast by Type (2019-2025)
Figure Global Pneumonia Vaccine Production (K Doses) Forecast by Type (2019-2025)
Table Global Pneumonia Vaccine Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Pneumonia Vaccine Revenue Market Share Forecast by Type (2019-2025)
Table Global Pneumonia Vaccine Price (USD/Dose) Forecast by Type (2019-2025)
Table Global Pneumonia Vaccine Consumption (K Doses) Forecast by Application (2019-2025)
Figure Global Pneumonia Vaccine Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us